What These Two Peptides Actually Are
BPC-157 is a synthetic pentadecapeptide derived from a gastric protein, while TB-500 is a synthetic fragment of thymosin beta-4 — they are structurally unrelated molecules that get grouped together only because research groups often run them in the same recovery-focused protocols. Treating them as interchangeable is the most common mistake in study design, because their origins and target profiles are different.
Sequence Origin and Structure
BPC-157 is a 15-amino-acid peptide, whereas TB-500 is a shorter thymosin beta-4 fragment — a difference that shows up immediately in MS confirmation and purity analysis. When you receive a COA, the expected mass will differ between the two, which is one of the quickest ways to confirm you got the right material.
Stability and Handling Differences
BPC-157 is generally regarded as more stable in solution than many peptides, while TB-500 should be kept lyophilized and handled carefully to preserve integrity. Both should be stored at -20°C, desiccated and light-protected until use, and aliquoted on first reconstitution to avoid repeated freeze-thaw cycles.
Practical Storage Checklist
- BPC-157: store lyophilized at -20°C, protect from light and moisture
- TB-500: same storage, but minimize handling time during reconstitution
- Both: aliquot upon first reconstitution — freeze-thaw degrades peptide integrity
- Both: request batch-specific COA with HPLC chromatogram + MS spectrum
How Research Groups Choose Between Them
Labs pick BPC-157 when the protocol centers on a gastric-derived peptide, and TB-500 when the hypothesis involves a thymosin beta-4 fragment — the choice follows the mechanism, not a generic “recovery” label. Some studies run both as separate arms precisely because they are not the same molecule. If your endpoint can’t distinguish the two mechanisms, running both together will muddy your readouts.
Purity Bar for Both
Accept ≥98% purity by HPLC with a single dominant peak for both BPC-157 and TB-500 — a number below 95% introduces impurities that can confound experimental results. Verify the mass spectrum matches the expected molecular weight for each, since a mix-up between two recovery peptides is a real-world sourcing risk when buying from unverified suppliers.
FAQ
Q: Are BPC-157 and TB-500 the same thing?
A: No — BPC-157 is a gastric-derived 15-amino-acid peptide, and TB-500 is a thymosin beta-4 fragment; they are structurally and mechanistically different. They are often mentioned together in recovery research, but that does not make them interchangeable.
Q: Which one is more stable in solution?
A: BPC-157 is generally considered more stable in solution than TB-500, but both should be stored lyophilized at -20°C and aliquoted on first reconstitution. Solution stability claims should always be checked against your own handling protocol.
Q: Can I verify I received the correct peptide?
A: Yes — the MS spectrum on the COA should match each peptide’s expected molecular weight, which differs between BPC-157 and TB-500. A mismatch is an immediate signal to stop and contact the supplier.
Q: Should I buy BPC-157 and TB-500 from the same supplier?
A: For traceability it is often cleaner to source both from one verified supplier, as long as each vial carries its own batch-specific COA. Confirm the lot numbers and chromatograms are distinct, not a shared template.